Thomas Peterson III is COO at Evolent Health, Inc. (EVH). They have made 12 open-market trades across 1 company since 2016, most recently 2018-09-13.
CIK 0001643498
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EVH | 137,868 | $630K |
Shares reported on the most recent Form 4, priced at the 2018-09-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EVH | SELL | 2018-09-13 | 2018-09-14 | $27.50 | $1.9M | +3.8% | -8.2% | -28.0% |
| EVH | SELL | 2018-08-30 | 2018-09-04 | $25.00 | $750K | +9.3% | +4.0% | -3.2% |
| EVH | SELL | 2018-08-01 | 2018-08-03 | $19.96 | $200K | +15.3% | +24.9% | +13.4% |
| EVH | SELL | 2018-07-02 | 2018-07-05 | $21.21 | $212K | +0.9% | -7.5% | +19.1% |
| EVH | SELL | 2018-06-01 | 2018-06-05 | $20.04 | $200K | +9.7% | +6.6% | +19.3% |
| EVH | SELL | 2018-05-14 | 2018-05-16 | $18.91 | $189K | +2.5% | +18.3% | +22.4% |
| EVH | SELL | 2017-07-24 | 2017-07-26 | $26.00 | $1.1M | -8.4% | -33.8% | -34.6% |
| EVH | SELL | 2017-05-19 | 2017-05-23 | $24.30 | $2.8M | +11.6% | +10.9% | -26.1% |
| EVH | SELL | 2017-05-15 | 2017-05-17 | $24.99 | $1.6M | -1.3% | +14.8% | -23.3% |
| EVH | SELL | 2017-05-12 | 2017-05-16 | $25.00 | $661K | -1.1% | +5.7% | -21.1% |
| EVH | SELL | 2017-05-10 | 2017-05-12 | $25.00 | $465K | -5.7% | -5.1% | -30.4% |
| EVH | SELL | 2016-09-14 | 2016-09-15 | $21.54 | $3.1M | -0.7% | +0.3% | -27.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.